Enable Your Drug Development Transformation Strategy with Structured Content & Data Management (SCDM)
In today’s complex drug development landscape, Criticality Analysis is more important than ever — helping you identify, prioritize, and manage the elements that have the greatest impact on product safety, efficacy, and regulatory success. The Criticality Analysis Application Summary outlines how this structured analytical approach drives better decisions, improves compliance, and accelerates delivery of lifesaving therapies.
What Is Criticality Analysis?
Criticality Analysis is a systematic method used throughout drug development to assess and prioritize the components, processes, and attributes that could influence product quality and performance. Integrating this analysis early and continuously supports both risk management and regulatory compliance — enabling quality-by-design across your portfolio.
- Identifies Critical Quality Attributes (CQAs)
- Evaluates Critical Material Attributes (CMAs)
- Assesses Critical Process Parameters (CPPs)
These structured insights guide development teams to focus on what matters most — from raw materials through production processes — reducing uncertainty and strengthening regulatory documentation.
Why It Matters
Drug development is a high-stakes, data-intensive process. Without a structured approach:
- Complex Biologics are difficult to analyze due to variability and process sensitivity.
- Data Overload hinders traceability and decision quality.
- Manual workflows increase risk of error and slow progress.
- Cross-functional collaboration becomes inconsistent.
Criticality Analysis provides the framework to turn complexity into clarity — allowing teams to optimize risk mitigation, improve product quality, and communicate confidence to regulators.
Introducing the Compass BIO Criticality Analysis Application
Built as part of the Compass BIO suite, the Criticality Analysis Application embeds structured content and data management (SCDM) into your development lifecycle:
Key Capabilities:
- Quality Attribute Repository: Pre-configured CQAs for reuse.
- Recipe & Process Definition: S88-standard process structuring.
- Scoring & Risk Tables: Rapid, data-driven prioritization.
- Automated Report Generation: Configurable, regulatory-ready outputs.
- Seamless Collaboration: One data set used across teams.
These capabilities transform how teams manage critical data — improving reproducibility, reducing manual effort, and strengthening regulatory submissions.
Get the Full Application Summary
Download now to explore how Criticality Analysis can elevate your biopharma processes — from early product design to regulatory submission.
Download the full whitepaper today!